NCT04459169View on ClinicalTrials.gov

Cardiac Amyloidosis : Diagnostic Using Red Flag Signals

UnknownOBSERVATIONAL
Enrollment

424

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

December 31, 2021

Conditions
Cardiac Amyloidosis
Interventions
PROCEDURE

diagnostic algorithm

Cardiac amyloidosis diagnosed according to Gillmore's algorithm

Trial Locations (3)

97100

NOT_YET_RECRUITING

Centre Hospitalier de Basse-Terre, Basse-Terre

97220

NOT_YET_RECRUITING

CHU de Martinique, La Trinité

97261

RECRUITING

CHU de Martinique, Fort-de-France

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Hospital Center of Martinique

OTHER

NCT04459169 - Cardiac Amyloidosis : Diagnostic Using Red Flag Signals | Biotech Hunter | Biotech Hunter